Načítá se...
The mc(2)-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects
Although the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccine has been used since 1921, tuberculosis (TB) control still proceeds at a slow pace. The main reason is the variable efficacy of BCG protection against TB among adults, which ranges from 0-80%. Subsequently, the mc(2)-C...
Uloženo v:
| Vydáno v: | Mem Inst Oswaldo Cruz |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Instituto Oswaldo Cruz, Ministério da Saúde
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830111/ https://ncbi.nlm.nih.gov/pubmed/27074251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-02760150411 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|